IL-1β induces serine protease inhibitor 3 (SPI-3) gene expression in rat pancreatic β-cells.: Detection by differential display of messenger RNA

被引:16
作者
Chen, MC [1 ]
Schuit, F [1 ]
Pipeleers, DG [1 ]
Eizirik, DL [1 ]
机构
[1] Free Univ Brussels, Ctr Diabet Res, B-1090 Brussels, Belgium
基金
新加坡国家研究基金会;
关键词
acute phase protein; beta-cells; DDRT-PCR; interleukin; 1; serine protease inhibitor-3;
D O I
10.1006/cyto.1999.0525
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Immune-mediated beta-cell damage induces diverse intracellular signals, leading to transcription of different genes which may either contribute to beta-cell repair and/or defence or lead to cell death. The cytokine interleukin-l beta (IL-1) is a potential mediator of beta-cell dysfunction and damage in type 1 diabetes mellitus, To understand the molecular actions of this cytokine upon beta-cells, this study aimed at the cloning of genes induced in FAGS-purified rat pancreatic beta-cells by a 6- or 24-h exposure to IL-1 by using differential display of mRNA with reverse transcription-polymerase chain reaction (DDRT-PCR), Among these cytokine-induced genes, a gene encoding for rat serine protease inhibitor (SPI-3) was isolated, SPI-3 may be involved in cellular defence responses against inflammatory stress, RT-PCR analysis confirmed that SPI-3 mRNA expression in rat beta-cells is increased by IL-l at an early stage (2 h), with maximal accumulation during 6-12 h and decline after 24 h, Similar observations were made in mouse pancreatic islets and in the rat insulinoma cell line RINm5F, IFN-gamma neither increased SPI-3 gene expression nor potentiated its induction by IL-1 in rat beta-cells, The stimulatory effects of IL-1 on SPI-3 mRNA expression were decreased by co-incubation with an inhibitor of gene transcription (actinomycin D), an inhibitor of protein synthesis (cycloheximide) or an inhibitor of NF-kappa B activation (PDTC), On the other hand, a blocker of inducible nitric oxide synthase (iNOS) activity (N-G-methyl-L-arginine) did not prevent IL-1-induced SPI-3 expression, Thus, SPI-3 mRNA expression following IL-1 exposure depends on gene transcription, protein synthesis and activation of the nuclear transcription factor NF-kappa B, but it is independent of NO formation, (C) 1999 Academic Press.
引用
收藏
页码:856 / 862
页数:7
相关论文
共 31 条
[1]   INSULIN-DEPENDENT DIABETES-MELLITUS AS A BETA-CELL TARGETED DISEASE OF IMMUNOREGULATION [J].
BACH, JF .
JOURNAL OF AUTOIMMUNITY, 1995, 8 (04) :439-463
[2]   IDENTIFICATION OF DIFFERENTIALLY EXPRESSED MESSENGER-RNA SPECIES BY AN IMPROVED DISPLAY TECHNIQUE (DDRT-PCR) [J].
BAUER, D ;
MULLER, H ;
REICH, J ;
RIEDEL, H ;
AHRENKIEL, V ;
WARTHOE, P ;
STRAUSS, M .
NUCLEIC ACIDS RESEARCH, 1993, 21 (18) :4272-4280
[3]   PYRROLIDINE DITHIOCARBAMATE PREVENTS IL-1-INDUCED NITRIC-OXIDE SYNTHASE MESSENGER-RNA, BUT NOT SUPEROXIDE-DISMUTASE MESSENGER-RNA, IN INSULIN-PRODUCING CELLS [J].
BEDOYA, FJ ;
FLODSTROM, M ;
EIZIRIK, DL .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 210 (03) :816-822
[4]   Regulation by cytokines of the inducible nitric oxide synthase promoter in insulin-producing cells [J].
Darville, MI ;
Eizirik, DL .
DIABETOLOGIA, 1998, 41 (09) :1101-1108
[5]   SHORT EXPOSURE OF RAT PANCREATIC-ISLETS TO INTERLEUKIN-1-BETA INDUCES A SUSTAINED BUT REVERSIBLE IMPAIRMENT IN BETA-CELL FUNCTION - INFLUENCE OF PROTEASE ACTIVATION, GENE-TRANSCRIPTION, AND PROTEIN-SYNTHESIS [J].
EIZIRIK, DL ;
BENDTZEN, K ;
SANDLER, S .
ENDOCRINOLOGY, 1991, 128 (03) :1611-1616
[6]   GENOTOXIC AGENTS INCREASE EXPRESSION OF GROWTH ARREST AND DNA DAMAGE - INDUCIBLE GENES GADD 153 AND GADD 45 IN RAT PANCREATIC-ISLETS [J].
EIZIRIK, DL ;
BJORKLUND, A ;
CAGLIERO, E .
DIABETES, 1993, 42 (05) :738-745
[7]   CYTOKINES SUPPRESS HUMAN ISLET FUNCTION IRRESPECTIVE OF THEIR EFFECTS ON NITRIC-OXIDE GENERATION [J].
EIZIRIK, DL ;
SANDLER, S ;
WELSH, N ;
CETKOVICCVRLJE, M ;
NIEMAN, A ;
GELLER, DA ;
PIPELEERS, DG ;
BENDTZEN, K ;
HELLERSTROM, C .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (05) :1968-1974
[8]  
Eizirik DL, 1996, DIABETOLOGIA, V39, P875
[9]  
Eizirik DL, 1997, DIABETES METAB REV, V13, P293, DOI 10.1002/(SICI)1099-0895(199712)13:4<293::AID-DMR195>3.3.CO
[10]  
2-W